Literature DB >> 9453578

Homophilic binding properties of galectin-3: involvement of the carbohydrate recognition domain.

S Kuklinski1, R Probstmeier.   

Abstract

Galectin-3, an animal lectin specific for beta-galactosides, is composed of three different domains. The N-terminal half of the molecule (N domain) consists of a short N-terminal segment followed by glycine-, proline-, and tyrosine-rich tandem repeats. The C-terminal domain (C domain) harbors the carbohydrate recognition domain homologous to other members of the galectin family of lectins. Galectin-3 aggregates in solution, and participation of the N domain of the molecule in this process has already been demonstrated. Using a solid-phase radioligand binding assay, which allows the direct analysis of galectin-3 self-association, here we provide evidence that the carbohydrate recognition domain of the lectin is involved in carbohydrate-dependent homophilic interactions: (a) Radiolabeled galectin-3 binds to immobilized galectin-3, and the addition of unlabeled galectin-3 in solution increases the rate of binding of radiolabeled lectin; (b) binding of radiolabeled galectin-3 to immobilized galectin-3 is inhibited by the C domain; (c) binding of radiolabeled galectin-3 to immobilized galectin-3 or the C domain is inhibited by lactose but not by sucrose; and (d) the radiolabeled C domain does not bind to immobilized C domain. Taken together, these data suggest that in addition to the N domain, the homophilic interactions of galectin-3 are mediated by the C domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453578     DOI: 10.1046/j.1471-4159.1998.70020814.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Kinetic measurements of binding of galectin 3 to a laminin substratum.

Authors:  E A Barboni; S Bawumia; R C Hughes
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

2.  How altering the modular architecture affects aspects of lectin activity: case study on human galectin-1.

Authors:  Tanja J Kutzner; Adele Gabba; Forrest G FitzGerald; Nadezhda V Shilova; Gabriel García Caballero; Anna-Kristin Ludwig; Joachim C Manning; Clemens Knospe; Herbert Kaltner; Fred Sinowatz; Paul V Murphy; Mare Cudic; Nicolai V Bovin; Hans-Joachim Gabius
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

3.  Differentiation-dependent modification and subcellular distribution of aquaporin-0 suggests multiple functional roles in the rat lens.

Authors:  Angus C Grey; Ling Li; Marc D Jacobs; Kevin L Schey; Paul J Donaldson
Journal:  Differentiation       Date:  2008-10-31       Impact factor: 3.880

4.  The intrinsically disordered N-terminal domain of galectin-3 dynamically mediates multisite self-association of the protein through fuzzy interactions.

Authors:  Yu-Hao Lin; De-Chen Qiu; Wen-Han Chang; Yi-Qi Yeh; U-Ser Jeng; Fu-Tong Liu; Jie-Rong Huang
Journal:  J Biol Chem       Date:  2017-09-11       Impact factor: 5.157

5.  Galectin-3 is associated with the plasma membrane of lens fiber cells.

Authors:  T Gonen; P Donaldson; J Kistler
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

6.  Ligand induced galectin-3 protein self-association.

Authors:  Adriana Lepur; Emma Salomonsson; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

7.  Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.

Authors:  Leonardo Mirandola; Yuefei Yu; Kitty Chui; Marjorie R Jenkins; Everardo Cobos; Constance M John; Maurizio Chiriva-Internati
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

Review 8.  Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments.

Authors:  Ana Carolina Ferreira Cardoso; Luciana Nogueira de Sousa Andrade; Silvina Odete Bustos; Roger Chammas
Journal:  Front Oncol       Date:  2016-05-23       Impact factor: 6.244

9.  Multivalent scaffolds induce galectin-3 aggregation into nanoparticles.

Authors:  Candace K Goodman; Mark L Wolfenden; Pratima Nangia-Makker; Anna K Michel; Avraham Raz; Mary J Cloninger
Journal:  Beilstein J Org Chem       Date:  2014-07-10       Impact factor: 2.883

Review 10.  Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Jennifer E Ho; Fu-Tong Liu; Rudolf A de Boer
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.